Skip to content
Search

Latest Stories

NPA wants competition watchdog to review 'hub and spoke' dispensing

To ensure fair competition and better functioning of hub and spoke dispensing, the National Pharmacy Association (NPA) wants the government's competition watchdog to review the model.

It wants the Department of Health and Social Care (DHSC) to ask the Competition and Markets Authority (CMA) to look into the system so that there is ample choice in the medicines supply chain and independent pharmacies are not deprived.


NPA vice-chair, Nick Kaye, said: “If the government believes that hub-and-spoke dispensing is the future for pharmacy, it must do more to allow independents to engage with the model on a level playing field and to prevent unintended consequences. This includes ensuring that pharmacies that do not have access to hub services, or choose not to use hub services, are not disadvantaged.

The NPA said that hubs should compete in a competitive market on the basis of quality of service and price for the custom of pharmacies. It also suggested five tests for maintaining fair competition and choice in the model.

  1. Hubs must be registered pharmacies and meet all GPhC/PSNI standards
  2. Hubs must be prevented from using their trusted position in the supply process to try to circumvent the relationship between the spoke and the patient
  3. The current barriers to entry for a hub provider presented by the direct to pharmacy (DTP) and limited wholesaler schemes must be removed
  4. A common set of standards should set out the duties and accountabilities of a dispensing hub and professional metrics
  5. Any mechanism which is designed to prevent a pharmacy from easily switching hub provider should be prevented

Further, the Human Medicines Regulations 2012 should be updated to put an obligation on all manufacturers to supply the reasonable needs of all registered pharmacies.

Kaye added: “The government should also ensure that manufacturer-controlled supply restrictions, which stifle competition along the supply chain, are swept away.

“The CMA is an obvious place to start for scrutinising the matter and achieving a competitive environment that works for independents and the NHS.”

More For You

 Government launches call for evidence on England’s first ever men’s health strategy

Wes Streeting

Pic credit: Getty images

Call for Evidence: Streeting urges public to help shape men’s health strategy

The government is urging men of all ages to come forward and contribute to the development of England’s first-ever men’s health strategy, a key initiative under its Plan for Change.

On Thursday (24), the Department of Health and Social Care (DHSC) launched a 12-week call for evidence, seeking insights from the public, health and social care professionals, academics and employers on ways to prevent and tackle the biggest issues facing men.

Keep ReadingShow less
GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less